Article
Impact of ABCB1 genetic polymorphism on carbamazepine dose requirement among Southern Indian persons with epilepsy.
Drug metabolism and personalized therapy - 1 Mar 2024
Dhivya Elango, Kesavan Ramasamy, Pradeep Nair P
Abstract excerpt
OBJECTIVES: Carbamazepine (CBZ) is one of the oldest, yet first line drugs for treating epilepsy. However, there is a large inter-individual difference in requirement of maintenance dose and one third of persons treated with antiepileptic drugs (AEDs) exhibit drug resistance to therapy. One of the proposed mechanisms for the drug resistance was increased expression of efflux transporter P-glycoprotein. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
